Skip to main content
. 2018 Oct 30;4(1):116–128. doi: 10.1002/btm2.10103

Table 3.

The fraction of antigen not released from microparticles in vitro during the soluble release phase can be accounted for via nitrogen analysis. Approximately 70% of encapsulated OVA was released as soluble antigen by day 35 from micropaticles. The remaining samples mass was found to contain approximately 27% of total encapsulated OVA, for 97% total recovery. ±SEM

% Soluble OVA release (day 35) % Remaining (N2 analysis) Total OVA recovery 1
69.9% ± 0.0 26.9% ± 0.0 96.8% ± 3.5